|
86 Companies |
|
137 Products |
|
137 Products |
|
85 Mechanisms of Action |
|
4 Trials |
|
2019 News |
|
| «12...4567891011121314...3940» |
- Enrollment closed, Enrollment change: Adaptive Treatment for Adolescent Cannabis Use Disorders (clinicaltrials.gov) - Dec 12, 2015
P=N/A, N=172, Active, not recruiting, Sponsor: University of Connecticut Health Center
Recruiting --> Active, not recruiting | N=230 --> 172
- clozapine / Generic mfg.
Trial initiation date, Trial primary completion date: Vitamin D for Schizophrenia (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=50, Recruiting, Sponsor: Geha Mental Health Center
Recruiting --> Active, not recruiting | N=230 --> 172 Initiation date: Jan 2013 --> May 2014 | Trial primary completion date: Jan 2014 --> Jun 2016
- amisulpride / Generic mfg., clozapine / Generic mfg.
Enrollment change, Trial withdrawal: Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=0, Withdrawn, Sponsor: Geha Mental Health Center
Initiation date: Jan 2013 --> May 2014 | Trial primary completion date: Jan 2014 --> Jun 2016 N=140 --> 0 | Recruiting --> Withdrawn
- |||| lurasidone / Generic mfg.
Trial completion: High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia (clinicaltrials.gov) - Dec 10, 2015
P4, N=101, Completed, Sponsor: Northwestern University
N=140 --> 0 | Recruiting --> Withdrawn Recruiting --> Completed
- metformin / Generic mfg., clozapine / Generic mfg.
Trial primary completion date: The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine (clinicaltrials.gov) - Dec 9, 2015
P4, N=30, Recruiting, Sponsor: Seoul National University Hospital
Recruiting --> Completed Trial primary completion date: Feb 2015 --> Apr 2016
- || paliperidone extended release / Generic mfg.
Trial primary completion date: Paliperidone ER(Invega (clinicaltrials.gov) - Dec 9, 2015
P4, N=70, Recruiting, Sponsor: Seoul National University Hospital
Trial primary completion date: Feb 2015 --> Apr 2016 Trial primary completion date: Mar 2014 --> Jul 2016
- Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J
Trial completion, Trial primary completion date: The Effect of Paliperidone Palmitate in Schizophrenia (clinicaltrials.gov) - Dec 9, 2015
P4, N=30, Completed, Sponsor: Seoul National University Hospital
Trial primary completion date: Mar 2014 --> Jul 2016 Recruiting --> Completed | Trial primary completion date: Mar 2014 --> Dec 2015
- Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J, Risperdal Consta (risperidone depot formulation) / J&J
Trial completion, Trial primary completion date: Switching From Consta (clinicaltrials.gov) - Dec 9, 2015
P=N/A, N=50, Completed, Sponsor: Seoul National University Hospital
Recruiting --> Completed | Trial primary completion date: Mar 2014 --> Dec 2015 Recruiting --> Completed | Trial primary completion date: Mar 2014 --> May 2015
- Kuvan (sapropterin) / BioMarin, Daiichi Sankyo
Trial primary completion date: Kuvan in People With Schizophrenia and Schizoaffective Disorder (clinicaltrials.gov) - Dec 6, 2015
P1/2, N=60, Suspended, Sponsor: New York State Psychiatric Institute
Recruiting --> Completed | Trial primary completion date: Mar 2014 --> May 2015 Trial primary completion date: Sep 2015 --> Feb 2016
- NN1213 / Novo Nordisk
Trial withdrawal: Behavioral Health Services for Women Receiving Public Assistance (clinicaltrials.gov) - Dec 5, 2015
P=N/A, N=0, Withdrawn, Sponsor: University of Pennsylvania
Trial primary completion date: Sep 2015 --> Feb 2016 Completed --> Withdrawn
- || aripiprazole / Generic mfg.
Trial primary completion date: Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=90, Recruiting, Sponsor: University of British Columbia
Completed --> Withdrawn Trial primary completion date: Sep 2015 --> Sep 2016
- Trial initiation date, Trial primary completion date: SPA: A System for Preference Assessment in Mental Health (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=95, Not yet recruiting, Sponsor: University of California, Los Angeles
Trial primary completion date: Sep 2015 --> Sep 2016 Initiation date: Jul 2015 --> Jan 2016 | Trial primary completion date: Dec 2015 --> Dec 2016
- Enrollment open, Trial initiation date, Trial primary completion date: RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia) (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=180, Recruiting, Sponsor: London School of Hygiene and Tropical Medicine
Initiation date: Jul 2015 --> Jan 2016 | Trial primary completion date: Dec 2015 --> Dec 2016 Not yet recruiting --> Recruiting | Initiation date: Jun 2015 --> Sep 2015 | Trial primary completion date: Mar 2016 --> Jan 2017
- Enrollment closed, Trial primary completion date: ASCI: Social Cognition Intervention (clinicaltrials.gov) - Nov 22, 2015
P=N/A, N=105, Active, not recruiting, Sponsor: VA Office of Research and Development
Not yet recruiting --> Recruiting | Initiation date: Jun 2015 --> Sep 2015 | Trial primary completion date: Mar 2016 --> Jan 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Dec 2015
- minocycline / Generic mfg., clozapine / Generic mfg.
Trial primary completion date: Minocycline Augmentation to Clozapine (clinicaltrials.gov) - Nov 17, 2015
P4, N=35, Recruiting, Sponsor: Emory University
Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2015 --> Dec 2015 Trial primary completion date: Sep 2015 --> Nov 2016
- Enrollment closed, Trial primary completion date: Therapeutic Efficacy of Transcranial Magnetic Stimulation in Schizophrenia (clinicaltrials.gov) - Nov 15, 2015
P2, N=30, Active, not recruiting, Sponsor: Beth Israel Deaconess Medical Center
Trial primary completion date: Sep 2015 --> Nov 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Nov 2015
- Trial primary completion date, Head-to-Head: TaSCS: Task Sharing for the Care of Severe Mental Disorders in a Low-income Country (clinicaltrials.gov) - Nov 14, 2015
P3, N=324, Recruiting, Sponsor: University of Cape Town
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Nov 2015 Trial primary completion date: Aug 2016 --> Jan 2017
- ||| F17464 / Pierre Fabre
Enrollment closed: F17464 in Acute Schizophrenia Trial (clinicaltrials.gov) - Nov 11, 2015
P2, N=142, Active, not recruiting, Sponsor: Pierre Fabre Medicament
Trial primary completion date: Aug 2016 --> Jan 2017 Recruiting --> Active, not recruiting
- Trial primary completion date: Cognitive Enhancement Therapy for Early-Stage Schizophrenia (clinicaltrials.gov) - Nov 10, 2015
P3, N=67, Active, not recruiting, Sponsor: Beth Israel Deaconess Medical Center
Recruiting --> Active, not recruiting Trial primary completion date: Aug 2007 --> Aug 2009
- Disalcid (salsalate) / Bausch Health
Trial primary completion date: Salsalate as an Adjunctive Treatment for Patients With Schizophrenia (clinicaltrials.gov) - Nov 9, 2015
P4, N=17, Active, not recruiting, Sponsor: University of Massachusetts, Worcester
Trial primary completion date: Aug 2007 --> Aug 2009 Trial primary completion date: Aug 2015 --> Dec 2015
- | Caplyta (lumateperone) - Intra / Cellular Therapies
Trial completion, Trial primary completion date: Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia (clinicaltrials.gov) - Nov 8, 2015
P2, N=14, Completed, Sponsor: Intra-Cellular Therapies, Inc.
Trial primary completion date: Aug 2015 --> Dec 2015 Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jul 2015
- ||||||| Caplyta (lumateperone) - Intra / Cellular Therapies
Trial completion: A Trial to Assess the Antipsychotic Efficacy of ITI-007 (clinicaltrials.gov) - Nov 8, 2015
P3, N=450, Completed, Sponsor: Intra-Cellular Therapies, Inc.
Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jul 2015 Active, not recruiting --> Completed
- ||||| aripiprazole / Generic mfg.
Enrollment closed, Trial primary completion date: A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia (clinicaltrials.gov) - Nov 6, 2015
P2/3, N=99, Active, not recruiting, Sponsor: Otsuka Pharmaceutical Co., Ltd.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Apr 2016
- | aripiprazole / Generic mfg.
Enrollment closed: A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia (clinicaltrials.gov) - Nov 6, 2015
P3, N=30, Active, not recruiting, Sponsor: Otsuka Pharmaceutical Co., Ltd.
Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Apr 2016 Recruiting --> Active, not recruiting
- ||||| lurasidone / Generic mfg.
Enrollment closed: Pediatric Schizophrenia Efficacy and Safety Study (clinicaltrials.gov) - Nov 5, 2015
P3, N=249, Active, not recruiting, Sponsor: Sunovion
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- clonidine / Generic mfg., dronabinol oral / Generic mfg.
Trial primary completion date: Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia (clinicaltrials.gov) - Oct 27, 2015
P2/3, N=18, Recruiting, Sponsor: Mclean Hospital
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2015 --> Mar 2016
- lamotrigine liquid oral suspension / OWP Pharma
Trial completion, Enrollment change, Trial primary completion date: EDIPP: Early Detection and Intervention for the Prevention of Psychosis (clinicaltrials.gov) - Oct 23, 2015
P=N/A, N=3337, Completed, Sponsor: Maine Medical Center
Trial primary completion date: Jun 2015 --> Mar 2016 Active, not recruiting --> Completed | N=350 --> 3337 | Trial primary completion date: May 2012 --> May 2013
- Trial primary completion date: Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=175, Active, not recruiting, Sponsor: Treatment Research Institute
Active, not recruiting --> Completed | N=350 --> 3337 | Trial primary completion date: May 2012 --> May 2013 Trial primary completion date: Sep 2015 --> Feb 2016
- Enrollment change, Trial withdrawal: Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia (clinicaltrials.gov) - Oct 22, 2015
P2, N=0, Withdrawn, Sponsor: New York University School of Medicine
Trial primary completion date: Sep 2015 --> Feb 2016 N=80 --> 0 | Recruiting --> Withdrawn
- isradipine / Generic mfg.
Enrollment change, Trial primary completion date: Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder (clinicaltrials.gov) - Oct 22, 2015
P=N/A, N=36, Recruiting, Sponsor: Icahn School of Medicine at Mount Sinai
N=80 --> 0 | Recruiting --> Withdrawn N=15 --> 36 | Trial primary completion date: Sep 2016 --> Jul 2017
- Enrollment change: Social Cognitive Training for Psychosis: Treatment Development (clinicaltrials.gov) - Oct 22, 2015
P1, N=58, Active, not recruiting, Sponsor: Yale University
N=15 --> 36 | Trial primary completion date: Sep 2016 --> Jul 2017 N=40 --> 58
- Trial completion, Enrollment change: Cognitive Behaviour Therapy and Cognitive Training in Work Rehabilitation for Persons With Severe Mental Illness (clinicaltrials.gov) - Oct 16, 2015
P=N/A, N=140, Completed, Sponsor: Oslo University Hospital
N=40 --> 58 Active, not recruiting --> Completed | N=240 --> 140
- Trial completion: Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD) (clinicaltrials.gov) - Oct 14, 2015
P=N/A, N=50, Completed, Sponsor: S
Active, not recruiting --> Completed | N=240 --> 140 Active, not recruiting --> Completed
- | clozapine / Generic mfg.
Trial completion: Electroconvulsive Therapy in Clozapine Refractory Schizophrenia (clinicaltrials.gov) - Oct 14, 2015
P1/2, N=39, Completed, Sponsor: North Shore Long Island Jewish Health System
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Trial initiation date, Trial primary completion date: AGES-CM: Intervention Module AGES (clinicaltrials.gov) - Oct 7, 2015
P=N/A, N=55, Completed, Sponsor: Celso Arango
Active, not recruiting --> Completed Not yet recruiting --> Completed | Initiation date: Apr 2014 --> Jan 2013 | Trial primary completion date: Apr 2018 --> Jul 2014
- L-threonic acid magnesium salt (NRCT-101) / Neurocentria
Trial primary completion date: Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia (clinicaltrials.gov) - Oct 6, 2015
P4, N=60, Recruiting, Sponsor: Northwestern University
Not yet recruiting --> Completed | Initiation date: Apr 2014 --> Jan 2013 | Trial primary completion date: Apr 2018 --> Jul 2014 Trial primary completion date: Sep 2015 --> Sep 2016
- || F17464 / Pierre Fabre
Trial primary completion date: F17464 in Acute Schizophrenia Trial (clinicaltrials.gov) - Oct 6, 2015
P2, N=142, Recruiting, Sponsor: Pierre Fabre Medicament
Trial primary completion date: Sep 2015 --> Sep 2016 Trial primary completion date: Oct 2015 --> Jan 2016
- Trial primary completion date: Computerised Interventions for Thinking and Anxiety in Delusions (CITADEL) Trial (clinicaltrials.gov) - Oct 6, 2015
P=N/A, N=46, Recruiting, Sponsor: King's College London
Trial primary completion date: Oct 2015 --> Jan 2016 Trial primary completion date: Sep 2015 --> Sep 2016
- Enrollment open, Trial initiation date, Trial primary completion date: A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia (clinicaltrials.gov) - Oct 6, 2015
P2, N=60, Recruiting, Sponsor: Massachusetts General Hospital
Trial primary completion date: Sep 2015 --> Sep 2016 Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> May 2015 | Trial primary completion date: Dec 2015 --> Dec 2016
- Trial completion, Trial primary completion date: TEAMcare for Diabetes in Mental Health Centers (clinicaltrials.gov) - Oct 5, 2015
P=N/A, N=35, Completed, Sponsor: University of Washington
Not yet recruiting --> Recruiting | Initiation date: Sep 2014 --> May 2015 | Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Sep 2015
- memantine ER / Generic mfg., galantamine extended release / Generic mfg.
Trial primary completion date: Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia (clinicaltrials.gov) - Sep 28, 2015
P2, N=10, Recruiting, Sponsor: Sheppard Pratt Health System
Recruiting --> Completed | Trial primary completion date: Apr 2015 --> Sep 2015 Trial primary completion date: Sep 2015 --> Sep 2017
- risperidone / Generic mfg., paliperidone extended release / Generic mfg.
Trial termination: A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia (clinicaltrials.gov) - Sep 28, 2015
P4, N=17, Terminated, Sponsor: Johnson & Johnson Taiwan Ltd
Trial primary completion date: Sep 2015 --> Sep 2017 Active, not recruiting --> Terminated; The study was terminated due to insufficient sample size and protocol compliance issue.
- Enrollment open: Very Low Nicotine Cigarettes in Smokers With Schizophrenia (clinicaltrials.gov) - Sep 28, 2015
P2, N=80, Recruiting, Sponsor: Brown University
Active, not recruiting --> Terminated; The study was terminated due to insufficient sample size and protocol compliance issue. Not yet recruiting --> Recruiting
- Trial completion: Acute Effects of Exercise in Smokers With Schizophrenia (clinicaltrials.gov) - Sep 28, 2015
P2, N=30, Completed, Sponsor: Brown University
Not yet recruiting --> Recruiting Recruiting --> Completed
- |||| lurasidone / Generic mfg.
Trial primary completion date: Pediatric Schizophrenia Efficacy and Safety Study (clinicaltrials.gov) - Sep 24, 2015
P3, N=249, Recruiting, Sponsor: Sunovion
Recruiting --> Completed Trial primary completion date: Aug 2015 --> Feb 2016
- Trial primary completion date: Probiotics to Prevent Relapse After Hospitalization for Mania (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=66, Enrolling by invitation, Sponsor: Sheppard Pratt Health System
Trial primary completion date: Aug 2015 --> Feb 2016 Trial primary completion date: Nov 2015 --> Dec 2016
- carbidopa/levodopa / Generic mfg.
Trial primary completion date: Antipsychotic Augmentation With L-Dopa (clinicaltrials.gov) - Sep 24, 2015
P2, N=24, Recruiting, Sponsor: Centre for Addiction and Mental Health
Trial primary completion date: Nov 2015 --> Dec 2016 Trial primary completion date: Sep 2015 --> Sep 2016
- olanzapine / Generic mfg., ziprasidone / Generic mfg.
Trial suspension, Trial primary completion date: Antipsychotics and Gene Expression in Soft Tissues (clinicaltrials.gov) - Sep 24, 2015
P4, N=42, Suspended, Sponsor: Medical University of Vienna
Trial primary completion date: Sep 2015 --> Sep 2016 Active, not recruiting --> Suspended | Trial primary completion date: Oct 2012 --> Dec 2017
- Enrollment closed, Trial primary completion date: The Assessment of Movement Disorders Utilizing Live Two-Way Video (clinicaltrials.gov) - Sep 24, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: North Shore Long Island Jewish Health System
Active, not recruiting --> Suspended | Trial primary completion date: Oct 2012 --> Dec 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2013 --> Jun 2016
- Trial completion: RECOVERY: RCT of Methotrexate Added to Treatment As Usual in Schizophrenia (clinicaltrials.gov) - Sep 22, 2015
P1, N=92, Completed, Sponsor: Pakistan Institute of Learning and Living
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2013 --> Jun 2016 Active, not recruiting --> Completed